We are live on
!
Find out more
EC
EntryPoint Capital Portfolio holdings
AUM
$341M
1-Year Est. Return
20.57%
This Fund
S&P 500
This Quarter
Est. Return
+2.29%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$112M
AUM Growth
+$7.22M
(+6.9%)
Cap. Flow
+$6.17M
Cap. Flow
% of AUM
5.54%
Top 10 Holdings %
Top 10 Hldgs %
3.56%
Holding
1,843
New
512
Increased
412
Reduced
454
Closed
458
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unisys
UIS
|
+$562K |
| 2 |
Fulgent Genetics
FLGT
|
+$385K |
| 3 |
Schrodinger
SDGR
|
+$384K |
| 4 |
Agilysys
AGYS
|
+$367K |
| 5 |
Riot Platforms
RIOT
|
+$344K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NextDecade
NEXT
|
+$565K |
| 2 |
American Well
AMWL
|
+$535K |
| 3 |
iHeartMedia
IHRT
|
+$499K |
| 4 |
BRC Group Holdings
RILY
|
+$497K |
| 5 |
Lexicon Pharmaceuticals
LXRX
|
+$496K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.49% |
| 2 | Industrials | 17.12% |
| 3 | Technology | 16.79% |
| 4 | Financials | 12.57% |
| 5 | Consumer Discretionary | 12.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Ciena
CIEN
$55.3B
| $9.2K | 0.01% |
186
+10
| +6% | +$528 |
|
1252
CVRx
CVRX
$126M
| $9.12K | 0.01% |
+501
| New | +$11.9K |
|
1253
Diageo
DEO
$46.2B
| $9.07K | 0.01% |
61
-282
| -82% | -$41.3K |
|
1254
Marten Transport
MRTN
$1.33B
| $9.04K | 0.01% |
489
-584
| -54% | -$11.2K |
|
|
SWAV
1255
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $8.79K | 0.01% |
27
-438
| -94% | -$108K |
|
1256
Xeris Biopharma Holdings
XERS
$1.44B
| $8.76K | 0.01% |
+3,963
| New | +$10.3K |
|
1257
Liberty Latin America Class A
LILA
$1.51B
| $8.71K | 0.01% |
+1,839
| New | +$8.42K |
|
1258
GDS Holdings
GDS
$6.34B
| $8.69K | 0.01% |
1,307
+1,290
| +7,588% | +$8.74K |
|
1259
Baidu
BIDU
$35.8B
| $8.63K | 0.01% |
82
-343
| -81% | -$36.5K |
|
|
JOYY
1260
JOYY Inc
JOYY
$3.73B
| $8.55K | 0.01% |
278
+94
| +51% | +$2.99K |
|
1261
Corebridge Financial
CRBG
$14.1B
| $8.27K | 0.01% |
288
-1,018
| -78% | -$25.1K |
|
1262
St. Joe Company
JOE
$3.57B
| $8.23K | 0.01% |
+142
| New | +$7.84K |
|
1263
Coca-Cola Femsa
KOF
$21.6B
| $8.16K | 0.01% |
84
+33
| +65% | +$3.16K |
|
1264
SoundHound AI
SOUN
$2.68B
| $8.1K | 0.01% |
1,375
-32,138
| -96% | -$127K |
|
|
AMPS
1265
DELISTED
Altus Power
AMPS
| $8.05K | 0.01% |
1,684
-23,663
| -93% | -$141K |
|
1266
Latham Group
SWIM
$646M
| $8.03K | 0.01% |
2,027
-34,323
| -94% | -$97.8K |
|
1267
Salesforce
CRM
$134B
| $7.83K | 0.01% |
+26
| New | +$7.5K |
|
1268
Silgan Holdings
SLGN
$4.91B
| $7.77K | 0.01% |
160
-3,225
| -95% | -$143K |
|
|
DNB
1269
DELISTED
Dun & Bradstreet
DNB
| $7.69K | 0.01% |
+766
| New | +$8.36K |
|
1270
PNC Financial Services
PNC
$100B
| $7.59K | 0.01% |
+47
| New | +$7.08K |
|
1271
Keurig Dr Pepper
KDP
$40.4B
| $7.51K | 0.01% |
245
+41
| +20% | +$1.26K |
|
|
FUSN
1272
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $7.44K | 0.01% |
+349
| New | +$4.17K |
|
1273
Pfizer
PFE
$140B
| $7.3K | 0.01% |
263
-426
| -62% | -$11.8K |
|
1274
American Express Global Business Travel
GBTG
$4.91B
| $7.19K | 0.01% |
+1,197
| New | +$7K |
|
1275
EastGroup Properties
EGP
$11.5B
| $7.19K | 0.01% |
40
-41
| -51% | -$7.39K |
|
Similar funds
SFA
FCM
CPI
SW
MTIC
KFSC
YCM
SC
EntryPoint Capital's Q1 2024 Portfolio in Review
As of Q1 2024, EntryPoint Capital held 1,843 positions worth $112M, up 6.9% from $104M the previous quarter. Its ten largest holdings account for 3.6% of the portfolio.
EntryPoint Capital deployed $6.17M of net new capital in Q1 2024, opening 512 new positions and adding to 412 existing holdings. Its largest new stake was Unisys: 92,556 shares worth $454K.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was NextDecade, an estimated $565K trimmed.
- EntryPoint Capital's largest Q1 2024 buy was Unisys: 92,556 shares worth $454K.
- EntryPoint Capital added most to Fulgent Genetics in Q1 2024, an estimated $385K increase.
- EntryPoint Capital's biggest Q1 2024 reduction was NextDecade, cutting an estimated $565K.
- EntryPoint Capital fully exited American Well in Q1 2024, selling an estimated $535K.
- EntryPoint Capital's ten largest holdings make up 3.6% of its $112M portfolio in Q1 2024.
- EntryPoint Capital opened 512 new positions and closed 458 in Q1 2024.
- EntryPoint Capital's portfolio value rose 6.9% quarter-over-quarter to $112M.
Based on EntryPoint Capital's 13F filing for Q1 2024, filed 14 May 2024.